Works matching IS 00278874 AND DT 2025 AND VI 117 AND IP 5

Results: 37
    1
    2

    Response to Lehrer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 1088, doi. 10.1093/jnci/djaf044
    By:
    • Roberts, Andrea L;
    • Kubzansky, Laura D;
    • Tworoger, Shelley S
    Publication type:
    Article
    3
    4
    5

    Response to Han and Liu.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 1082, doi. 10.1093/jnci/djaf026
    By:
    • Lo, Serigne N;
    • Varey, Alexander H R;
    • Ch'ng, Sydney;
    • Scolyer, Richard A;
    • Thompson, John F
    Publication type:
    Article
    6
    7
    8

    Response to Oleribe.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 1078, doi. 10.1093/jnci/djaf020
    By:
    • Riviere, Paul;
    • Murphy, James D;
    • Vitzthum, Lucas K
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 1018, doi. 10.1093/jnci/djae349
    By:
    • McWilliam, Alan;
    • Marshall, Deborah;
    • Kerns, Sarah L;
    • Barnett, Gillian C;
    • Vega, Ana;
    • Kapouranis, Thodori;
    • Barrera, Miguel E Aguado;
    • Avuzzi, Barbara;
    • Azria, David;
    • Chang-Claude, Jenny;
    • Choudhury, Ananya;
    • Costa, Carla Coedo;
    • Dunning, Alison;
    • Farcy-Jacquet, Marie-Pierre;
    • Faivre-Finn, Corinne;
    • Gutiérrez-Enríquez, Sara;
    • Fuentes-Ríos, Olivia;
    • Caamaño, Antonio Gómez;
    • Lambrecht, Maarten;
    • Pleguezuelos, Carlos López
    Publication type:
    Article
    22
    23

    TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 1069, doi. 10.1093/jnci/djae334
    By:
    • Lolas-Hamameh, Suhair;
    • Lieberman, Sari;
    • Sarahneh, Alaa;
    • Walsh, Tom;
    • Lee, Ming K;
    • Gulsuner, Suleyman;
    • Rabie, Grace;
    • Beeri, Rachel;
    • Aburayyan, Amal;
    • Mandell, Jessica B;
    • Fridman, Hila;
    • Lazer-Derbeko, Galit;
    • Klopstock, Tehila;
    • Freireich, Orit;
    • Lahad, Amnon;
    • King, Mary-Claire;
    • Levy-Lahad, Ephrat;
    • Kanaan, Moien N
    Publication type:
    Article
    24
    25

    Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 934, doi. 10.1093/jnci/djae329
    By:
    • Buqué, Aitziber;
    • Bloy, Norma;
    • Petroni, Giulia;
    • Jiménez-Cortegana, Carlos;
    • Sato, Ai;
    • Iribarren, Cristina;
    • Yamazaki, Takahiro;
    • Galassi, Claudia;
    • Hensler, Michal;
    • Bhinder, Bhavneet;
    • Guarracino, Andrea;
    • Rippon, Brady;
    • Beltran-Visiedo, Manuel;
    • Soler-Agesta, Ruth;
    • Pannellini, Tania;
    • Fucikova, Jitka;
    • Demaria, Sandra;
    • Zhou, Xi Kathy;
    • Elemento, Olivier;
    • Formenti, Silvia C
    Publication type:
    Article
    26

    Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 924, doi. 10.1093/jnci/djae327
    By:
    • Wheeler, Cosette M;
    • Adcock, Rachael;
    • Hunt, William C;
    • Robertson, Michael;
    • Torrez-Martinez, Norah E;
    • McDonald, Ruth;
    • Merchasin, Emily;
    • Jenison, Steven;
    • Saslow, Debbie;
    • Joste, Nancy E;
    • Castle, Philip E;
    • Kim, Jane J;
    • Cuzick, Jack;
    • Members, New Mexico HPV Pap Registry Steering Committee
    Publication type:
    Article
    27
    28
    29
    30

    Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 889, doi. 10.1093/jnci/djae314
    By:
    • Abdou, Yara;
    • Barlow, William E;
    • Gralow, Julie R;
    • Meric-Bernstam, Funda;
    • Albain, Kathy S;
    • Hayes, Daniel F;
    • Lin, Nancy U;
    • Perez, Edith A;
    • Goldstein, Lori J;
    • Chia, Stephen K L;
    • Dhesy-Thind, Sukhbinder;
    • Rastogi, Priya;
    • Alba, Emilio;
    • Delaloge, Suzette;
    • Schott, Anne F;
    • Shak, Steven;
    • Sharma, Priyanka;
    • Lew, Danika L;
    • Miao, Jieling;
    • Unger, Joseph M
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 5, p. 868, doi. 10.1093/jnci/djae268
    By:
    • Johansson, Annelie;
    • Dar, Huma;
    • Nordenskjöld, Anna;
    • Perez-Tenorio, Gizeh;
    • Tobin, Nicholas P;
    • Yau, Christina;
    • Benz, Christopher C;
    • Esserman, Laura J;
    • Veer, Laura J van 't;
    • Nordenskjöld, Bo;
    • Stål, Olle;
    • Fornander, Tommy;
    • Lindström, Linda S
    Publication type:
    Article